NCT02768558 2021-06-02
Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC
RTOG Foundation, Inc.
Phase 3 Terminated
RTOG Foundation, Inc.
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC